无活化CDKN2AARF促进p53-独立的PDAC瘤微环境的重塑
Sofia Ferreira1, Brittany M Flowers1, Won-Young Choi2
1Stanford University Stanford, CA United States.
Cancer research
|March 11, 2026
概括
由CDKN2A基因编码的瘤抑制剂ARF抑制胰腺管腺癌 (PDAC) 的发展,并独立于p53.3重新塑造瘤微环境 (TME). 这种ARF缺陷促进了PDAC的进展和治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- CDKN2A位点编码了两个瘤抑制剂,ARF和INK4A,在胰腺导管腺癌 (PDAC) 中经常被删除.
- 了解ARF和INK4A在PDAC病变发生中的不同作用对于识别治疗漏洞至关重要.
- 在PDAC开发中ARF的p53独立功能需要进一步阐明.
研究的目的:
- 研究ARF在抑制胰腺管道腺癌 (PDAC) 中的作用.
- 要确定ARF的瘤抑制功能是否独立于p53.
- 描述ARF缺乏如何影响PDAC中的瘤微环境 (TME).
主要方法:
- 对CDKN2A表达和突变模式的人类TCGA数据的分析.
- 使用基因工程小鼠模型 (GEMMs) 研究KRASG12D驱动的PDAC中的Arf无活化.
- 对PDAC的转录组分析以确定与ARF缺乏相关的基因表达变化.
- 在ARF缺乏的PDAC中对瘤微环境 (TME) 的组织学和生物化学评估.
主要成果:
- 在PDAC中,CDKN2AARF和CDKN2AINK4A的联合失活是常见的.
- 在小鼠中,ARF无活化加速了KRASG12D驱动的PDAC发育,无论Trp53状态如何,这证实了ARF是独立于p53.3的PDAC抑制剂.
- ARF缺乏促进了与细胞外基因矩阵重塑,原合成和上皮-介质酶过渡相关的基因表达程序.
- 缺乏ARF的PDACs表现出一种脱塑性TME,与增加的原沉积,组织硬性和纤维细胞透.
结论:
- ARF作为PDAC中的瘤抑制剂,可以以p53独立的方式起作用.
- ARF缺陷显著重塑了PDAC瘤微环境 (TME),促进了纤维化和侵略性的肌层.
- 这些发现突显了ARF在PDAC病变发生过程中的重要性,并表明其无活化有助于治疗耐药性,为改进治疗策略提供了潜在的目标.
相关概念视频
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K


